Wockhardt Plunges After US Drug Regulator Warns Subsidiary

New Delhi: Shares of Wockhardt today fell sharply by nearly 7 per cent after the company said the US health regulator has issued a warning letter to its step down subsidiary Morton Grove Pharmaceuticals Inc.  After a weak opening, shares of the company further went down by 6.67 per cent to Rs 701 on BSE. On NSE, shares of the company slipped 6.53 per cent to Rs 701.  "The United States Food and Drug Administration (USFDA) has iss...